Harbour Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Harbour Capital Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3,793	Closed	-$240K	–	233
2018 Q1	$240K	Sell	3,793 -17,000	-82%	-$1.09M	0.1%	214
2017 Q4	$1.27M	Buy	20,793 +735	+4%	+$46K	0.53%	61
2017 Q3	$1.28M	Sell	20,058 -1,295	-6%	-$75.6K	0.56%	49
2017 Q2	$1.19M	Sell	21,353 -370	-2%	-$20.1K	0.59%	53
2017 Q1	$1.18M	Hold	21,723	–	–	0.54%	53
2016 Q4	$1.27M	Sell	21,723 -190	-0.9%	-$10.4K	0.91%	30
2016 Q3	$1.18M	Buy	21,913 +5,400	+33%	+$347K	0.74%	31
2016 Q2	$1.22M	Sell	16,513 -310	-2%	-$21.9K	0.68%	31
2016 Q1	$1.07M	Buy	16,823 +5	+0%	+$315	0.61%	43
2015 Q4	$1.16M	Buy	16,818 +1,145	+7%	+$75.7K	0.63%	46
2015 Q3	$928K	Buy	15,673 +1,395	+10%	+$88.5K	0.66%	52
2015 Q2	$950K	Buy	14,278 +2,365	+20%	+$156K	0.59%	54
2015 Q1	$768K	Buy	11,913 +1,575	+15%	+$98.6K	0.54%	65
2014 Q4	$610K	Buy	+10,338	New	+$583K	0.44%	82

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harbour Capital Advisors's BMY Position: Q2 2018 in Review

Harbour Capital Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2018, closing a stake of 3,793 shares — an estimated $240K sold.

Harbour Capital Advisors first reported a position in BMY in Q4 2014 and held it in 14 quarters. The position peaked at $1.28M in Q3 2017. 1,691 funds tracked by Wall St. Rank hold BMY as of Q2 2018.

Harbour Capital Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2018 after selling out during the quarter.
Harbour Capital Advisors sold 3,793 Bristol-Myers Squibb shares in Q2 2018, an estimated $240K.
Harbour Capital Advisors first reported a position in Bristol-Myers Squibb in Q4 2014 and held it in 14 quarters.
Harbour Capital Advisors's Bristol-Myers Squibb position peaked at $1.28M in Q3 2017.
1,691 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2018.

Based on Harbour Capital Advisors's 13F filing for Q2 2018, filed 11 Jul 2018.